Through the activation of the PI3K/Akt/GSK-3 pathway, Liangyuan Chen et al. 64 67 discovered that LDHC increased lung adenocarcinoma cell proliferation, migration, invasion, and epithelial-mesenchymal transition. Here, LDHC is linked to lung adenocarcinoma.